Lubirine Interpharma treatment for hyper -hyperplasia, cirrhosis (10 blisters x 10 tablets)

Dosage form Soft capsules
Specifications Box of 10 blisters x 10 tablets
Ingredient L-Ornithine-L-ASPARTATE

Ingredient

Composition information	Content
L-Ornithine-L-ASPARTATE	300mg

Uses

Indications

Lubirine is an amino acid used in the treatment of hyperiemia, cirrhosis and cerebral liver disease.

Pharmacological

No data.

pharmacokinetics

No data.

Before taking Lubirine Interpharma treatment for hyper -hyperplasia, cirrhosis (10 blisters x 10 tablets)

How to use

Lubirine drug used oral, after eating.

Dosage

recommended dose:

Adults: 1 - 3 capsules/time x 3 times/day, after eating, for 1-2 weeks.

Maintain: 1 tablet x 3 times daily for 4-5 weeks depending on the doctor's instructions.

Note: The above dose is for reference only. Specific dosage depends on the condition and level of progression of the disease. For a suitable dose, you need to consult a doctor or medical specialist.

What to do when overdose?

In an emergency, call the 115 emergency center immediately or go to the nearest local health station.

What to do when you forget 1 dose? However, if the time to relax with the next dose is too short, skip the dose and continue the calendar of the drug. Do not use double dose to compensate for missed dose.

Side Effects

When using lubirine drugs often experience unwanted effects (ADR) such as:

L-Ornithine L-Aspartate has no clear side effects. Nausea, transient vomiting may occur.

Notify the physician the unwanted effects when using the drug.

Warnings

Before using the drug you need to read the instructions carefully and refer to the information below.

contraindicated

Lubirine drugs contraindicated in the following cases:

Patients with hypersensitivity to any component of the drug.

Be cautious when using

Do not use the drug when the drug expires or there is a change in smell or color.

Children, the elderly, pregnant and lactating women.

The effect of the drug on the ability to drive and operate machinery

unknown effects of the drug.

Use drugs for women during pregnancy and lactation

The safety of the drug when used for pregnant and lactating women has not been determined. Only use this medication for pregnant and lactating women when considering the benefits of treatment and risks may occur.

Interactive drug

There is no report on the interaction of this drug and other drugs.

Storage

In closed boxes, at temperatures below 30C, avoid light.

Other drugs

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.